Metraipolis › archive › dc_ccef1df4f24d
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor — Europe PMC PMID:41695591
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41695591
- DOI
- 10.1039/d5md01081k
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T11:05:41.703Z
- SHA-256 of the archived text
1bb246fd0646ed04c67dbe30463b08583fe8489972408c028c14804c1760ea07- Stable URL of this page
https://metraipolis.com/documento/dc_ccef1df4f24d
How to cite
Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor — Europe PMC PMID:41695591 — Europe PMC (en), https://europepmc.org/article/MED/41695591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccef1df4f24d (Metraipolis archive dc_ccef1df4f24d, sha256 1bb246fd0646ed04c67dbe30463b08583fe8489972408c028c14804c1760ea07)
BibTeX
@misc{dcccef1df4f24d,
title = {Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor — Europe PMC PMID:41695591},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41695591},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccef1df4f24d; sha256 1bb246fd0646ed04c67dbe30463b08583fe8489972408c028c14804c1760ea07},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41695591. Agents can read the archived copy with the MCP tool read_document.